Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 6
2016 26
2017 23
2018 29
2019 19
2020 32
2021 45
2022 37
2023 38
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
EFFECT OF PAXLOVID TREATMENT DURING ACUTE COVID-19 ON LONG COVID ONSET: AN EHR-BASED TARGET TRIAL EMULATION FROM THE N3C AND RECOVER CONSORTIA.
Preiss A, Bhatia A, Aragon LV, Baratta JM, Baskaran M, Blancero F, Brannock MD, Chew RF, Díaz I, Fitzgerald M, Kelly EP, Zhou A, Carton TW, Chute CG, Haendel M, Moffitt R, Pfaff E. Preiss A, et al. medRxiv [Preprint]. 2024 Apr 4:2024.01.20.24301525. doi: 10.1101/2024.01.20.24301525. medRxiv. 2024. PMID: 38343863 Free PMC article. Preprint.
Nonelective coronary artery bypass graft outcomes are adversely impacted by Coronavirus disease 2019 infection, but not altered processes of care: A National COVID Cohort Collaborative and National Surgery Quality Improvement Program analysis.
Grimsley EA, Torikashvili JV, Janjua HM, Read MD, Kothari AN, Verhagen NB, Pietrobon R, Kuo PC, Rogers MP; N3C Consortium. Grimsley EA, et al. JTCVS Open. 2023 Sep 22;16:342-352. doi: 10.1016/j.xjon.2023.09.020. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204718 Free PMC article.
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.
Mitra AK, Mukherjee UK, Mazumder S, Madhira V, Bergquist T, Shao YR, Liu F, Song Q, Su J, Kumar S, Bates BA, Sharafeldin N, Topaloglu U; National COVID Cohort Collaborative Consortium. Mitra AK, et al. Blood Cancer J. 2023 Dec 7;13(1):180. doi: 10.1038/s41408-023-00901-y. Blood Cancer J. 2023. PMID: 38057320 Free PMC article.
Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.
Hill EL, Mehta HB, Sharma S, Mane K, Singh SK, Xie C, Cathey E, Loomba J, Russell S, Spratt H, DeWitt PE, Ammar N, Madlock-Brown C, Brown D, McMurry JA, Chute CG, Haendel MA, Moffitt R, Pfaff ER, Bennett TD; N3C Consortium; and the RECOVER Consortium. Hill EL, et al. BMC Public Health. 2023 Oct 25;23(1):2103. doi: 10.1186/s12889-023-16916-w. BMC Public Health. 2023. PMID: 37880596 Free PMC article.
233 results